PSMA therapy under more restrictive regimen of 4-week intervals
发表于: 10 11 月, 2021
How oft is the Lu-PSMA treatment conducted? The usual c…
Ga-68 demonstrates superiority to F-18 in digital PSMA-PET/CT scans for staging prostate cancer
发表于: 10 11 月, 2021
Fluorine-18 is a commonly used isotope utilized for con…
PSMA therapy improves health-related quality of life in patients with prostate cancer
发表于: 24 9 月, 2021
On Friday, 17 September 2021, Novartis announced furthe…
NCCN Guidelines add PSMA-PET imaging for prostate cancer
发表于: 17 9 月, 2021
National Comprehensive Cancer Network, an alliance of c…
Working group headed by Prof. Markus Hartenbach was able to demonstrate the outstanding diagnostic value of PSMA PET / MRI in biopsy-proven prostate cancer
发表于: 13 12 月, 2019
Working group headed by Prof. Markus Hartenbach was abl…
Working group under Prof. Hartenbach MD demonstrates superiority of PSMA PET in diagnosing recurring prostate cancer
发表于: 13 12 月, 2019
The working group headed by Prof. Markus Hartenbach MD …
Markus Hartenbach wins Oncology Council’s Young Investigator Award
发表于: 13 12 月, 2019
Markus Hartenbach wins Oncology Council’s Young Investi…
NET Patient Education Conference of NET Research Foundation on Theranostics (PRRT)
发表于: 10 11 月, 2021
Video: Nuclear imaging 68Ga-DOTATATE and PRRT 177Lu-DOT…
二氯化镭-223 治疗(Xofigo®)
发表于: 13 12 月, 2019
Alpha emitter radium-223 and survival in metastatic pro…
